-
2341
A retrospective study of pembrolizumab combined with XELOX regimen in the treatment of advanced gastric cancer
Published 2024-11-01“…Therefore, exploring effective treatment options remains a key focus of clinical research. As a new type of immune checkpoint inhibitor, the clinical efficacy and safety of pembrolizumab still need to be confirmed by extensive research. …”
Get full text
Article -
2342
-
2343
-
2344
-
2345
Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma
Published 2021-04-01Get full text
Article -
2346
Tertiary Lymphoid Structure in Dental Pulp: The Role in Combating Bacterial Infections
Published 2025-01-01Get full text
Article -
2347
-
2348
-
2349
Pilot study of a ketogenic diet in bipolar disorder: a process evaluation
Published 2025-01-01“…Future trials may benefit from increased clinical research capacity, better-defined entry and exit routes, additional interpersonal support, and greater understanding of how social and societal factors impact participation. …”
Get full text
Article -
2350
-
2351
-
2352
Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation
Published 2025-02-01Get full text
Article -
2353
-
2354
-
2355
Measurable residual disease as predictor of post–day +100 relapses after allografting in adult AML
Published 2025-02-01Get full text
Article -
2356
-
2357
Integrated analysis of the prevalence and influencing factors of poststroke dysphagia
Published 2025-01-01Get full text
Article -
2358
-
2359
-
2360
Uncovering the Mechanisms of BaBaoWuDanYaoMo Against Influenza A Virus and Virus-Induced Inflammation Based on Network Pharmacology and Pharmacological Evaluation
Published 2025-01-01“…Biao Lei,1,* Yongjie Su,1,* Ruihan Chen,1,* Zexing Chen,1,* Bin Liu,1 Yuou Chen,1,2 Meihua Zhou,1 Xinhua Wang,1,3 Qinhai Ma1 1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, Guangdong, People’s Republic of China; 2King Med School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, Guangdong, People’s Republic of China; 3Institute of Integration of Traditional and Western Medicine, Guangzhou Medical University, Guangzhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qinhai Ma; Xinhua Wang, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People’s Republic of China, Email 13268268214@163.com; xinhuaw@gzhmu.edu.cnPurpose: The pro-inflammatory response triggered by influenza viruses can contribute to viral pneumonia, even death. …”
Get full text
Article